← Back to Clinical Trials
Recruiting NCT07056504

NCT07056504 Technologies and Systems for Assessing Human Energy Metabolism and Nutritional Rehabilitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07056504
Status Recruiting
Phase
Sponsor Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Condition Energy Metabolism
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2025-07-09
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 70 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 80 participants in total. It began in 2025-07-09 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this observational study is to integrate the doubly labeled water (DLW) database from healthy individuals with multimodal data-including, but not limited to, weight, height, age, sex, race, elevation-from cohorts undergoing rehabilitation following movement impairments or neurological injuries. Machine learning algorithms will be used to develop injury-specific predictive models of energy requirements. The primary research question is: How does energy metabolism change during the rehabilitation process in individuals recovering from traumatic brain injury, stroke, or major surgical procedures? To answer this, participants will undergo a comprehensive set of assessments, including measurements of height and weight, body composition, resting metabolic rate, physical activity levels, total energy expenditure, psychological health, food intake and hunger ratings, sleep quality, cognitive performance, non-invasive brain function monitoring, and gait analysis. Fecal and blood samples will also be collected for untargeted metabolomics analysis.

Eligibility Criteria

Inclusion Criteria: * Male and female participants aged 20 to 70 years old; * Rehabilitation patients with stroke or motor injuries; Exclusion Criteria: * Loss of autonomous mobility; * Loss of consciousness; * Individuals with metallic implants (e.g., pacemakers); * Severe metabolic diseases (e.g., diabetes, other hereditary metabolic disorders); * Patients with claustrophobia; * Individuals with anorexia nervosa; * Women in the preconception period, pregnancy, or lactation; * Uremic patients; * Inability to lie flat for one hour.

Contact & Investigator

Central Contact

Xueying Zhang, Doctor

✉ zhangxy@siat.ac.cn

📞 86+18201296155

Principal Investigator

Xueying Zhang, PhD

PRINCIPAL INVESTIGATOR

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Frequently Asked Questions

Who can join the NCT07056504 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Energy Metabolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07056504 currently recruiting?

Yes, NCT07056504 is actively recruiting participants. Contact the research team at zhangxy@siat.ac.cn for enrollment information.

Where is the NCT07056504 trial being conducted?

This trial is being conducted at Foshan, China.

Who is sponsoring the NCT07056504 clinical trial?

NCT07056504 is sponsored by Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences. The principal investigator is Xueying Zhang, PhD at Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology